Osaic Holdings
PCRX icon

Osaic Holdings’s Pacira BioSciences PCRX Stock Holding History

Osaic Holdings’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5
Closed -$1K – 6916
2020
Q4 		$1K Hold
5
– – ﹤0.01% 6249
2020
Q3 		$4K Buy
+5
New +$291 ﹤0.01% 5653

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's PCRX Position: Q2 2026 in Review

Osaic Holdings reduced its Pacira BioSciences (PCRX) stake by 2.3% in Q2 2026, selling an estimated $9.22K and leaving 16,588 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #3805.

Osaic Holdings first reported a position in PCRX in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.76M in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Osaic Holdings held 16,588 shares of Pacira BioSciences worth $421K as of Q2 2026.
  • Osaic Holdings sold 390 Pacira BioSciences shares in Q2 2026, an estimated $9.22K.
  • Pacira BioSciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3805 holding.
  • Osaic Holdings first reported a position in Pacira BioSciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Pacira BioSciences position peaked at $1.76M in Q1 2022.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.